James Carr

Director - US Supply Chain & Procurement Legend Biotech

James is a supply chain and procurement leader with over five years at Legend Biotech, driving reliability and scalability across the CAR-T and advanced therapy supply network. He currently serves as Director of US Supply Chain & Procurement, overseeing end-to-end supply chain strategy, planning, logistics, and procurement operations. He also led Global Procurement – Direct Materials, where he built global sourcing capabilities, governance frameworks, and processes while supporting the formation of a sourcing organization for Carvykti. His earlier roles include Associate Director of US Supply Chain and Site Supply Chain Lead for Raritan’s CAR-T operations, ensuring seamless, patient-focused supply continuity.

Seminars

Thursday 11th June 2026
Scaling Smart: Transitioning from R&D to Commercial Operations for Broader Patient Access
9:00 am
  •  Building operational efficiency to reduce costs while maintaining speed, reliability, and quality in therapy delivery
  • Prioritizing commercial capabilities alongside scientific expertise to support larger patient populations and sustainable growth
  • Re-evaluating processes for scalability, reliability, and strong unit economics to ensure cost-effective operations without compromising therapy integrity
Thursday 11th June 2026
Roundtable: Driving Integration to Reduce Fragmentation & Build a Resilient CGT Supply Chain Network
2:00 pm
  •  Exploring integration as a solution to improve industry standards, consistency, and operational reliability
  • Reviewing the relationship between increased integration and standardization to identify efficiencies and reduce errors across the CGT supply chain
  • Imagining the CGT industry 5 years from now to define what a fully integrated, patient-centric ecosystem could look like
  • Generating practical actionable insights to help stakeholders implement deeper integration and strengthen supply chain resilience
Legend Biotech Logo